Amitriptyline attenuates interstitial inflammation and ameliorates the progression of renal fibrosis

Kidney International

Volumn 75, Issue 6, 2009, Pages 596-604

  Achar, Eduardo ^a,b   Maciel, Thiago T ^a   Collares, Carlos F ^b,c   Teixeira, Vicente P C ^a   Schor, Nestor ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b MASTERS AND DOCTORAL PROGRAMS IN PHYSICAL THERAPY   (Brazil)

^c Hospital Municipal Dr Arthur Ribeiro de Saboya   (Brazil)

Author keywords

Amitriptyline; Inflammation; Tubulointerstitial fibrosis; Unilateral ureteral obstruction

Indexed keywords

AMITRIPTYLINE; INTERCELLULAR ADHESION MOLECULE 1; MOLECULAR MARKER; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; FIBROSING ALVEOLITIS; INFLAMMATION; KIDNEY FIBROSIS; KIDNEY FUNCTION; MACROPHAGE; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; URETER OBSTRUCTION; X IRRADIATION;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOLOGICAL MARKERS; CELL MOVEMENT; DISEASE PROGRESSION; FIBROSIS; INFLAMMATION; KIDNEY DISEASES; MACROPHAGES; MICE; MICE, INBRED C57BL;

EID: 61349105915     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.578     Document Type: Article

References (40)

1. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-1666.
2. Becker GJ, Hewitson TD. The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hypertens 2000; 9: 133-138.
3. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002; 283: F861-F875.
4. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7: 2495-2508.
5. Klahr S, Morrissey JJ. Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int Suppl 1997; 63: S111-S114.
6. Diamond JR, Kees-Folts D, Ding G et al. Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 1994; 266: F926-F933.
7. Kitagwa K, Wada T, Furuichi K et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 2009; 165: 237-296.
8. Giachelli CM, Pichler R, Lombardi D et al. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994; 45: 515-524.
9. Ricardo SD, Levinson ME, DeJoseph MR et al. Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int 1996; 50: 2002-2010.
10. Goncalves RG, Biato MA, Colosimo RD et al. Effects of mycophenolate mofetil and lisinopril on collagen deposition in unilateral ureteral obstruction in rats. Am J Nephrol 2004; 24: 527-536.
11. Vieira Jr JM, Mantovani E, Rodrigues LT et al. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol Dial Transplant 2005; 20: 1582-1591.
12. Wu MJ, Wen MC, Chiu YT et al. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int 2006; 69: 2029-2036.
13. Achar E, Achar RA, Paiva TB et al. Amitriptyline eliminates calculi through urinary tract smooth muscle relaxation. Kidney Int 2003; 64: 1356-1364.
14. Max MB, Lynch SA, Muir J et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326: 1250-1256.
15. Theoharides TC. The mast cell: a neuroimmunoendocrine master player. Int J Tissue React 1996; 18: 1-21.
16. Mochizucki D. Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Hum Psychopharmacol 2004; 19(Suppl 1): S15-S19.
17. Hanno PM. Amitriptyline in the treatment of interstitial cystitis. Urol Clin North Am 1994; 21: 89-91.
18. Moldwin RM, Sant GR. Interstitial cystitis: a pathophysiology and treatment update. Clin Obstet Gynecol 2002; 45: 259-272.
19. Chew DJ, Buffington CA, Kendall MS et al. Amitriptyline treatment for severe recurrent idiopathic cystitis in cats. J Am Vet Med Assoc 1998; 213: 1282-1286.
20. Abdel-Salam OM, Nofal SM, El-Shenawy SM. Evaluation of the antiinflammatory and anti-nociceptive effects of different antidepressants in the rat. Pharmacol Res 2003; 48: 157-165.
21. Obuchowicz E, Kowalski J, Labuzek K et al. Amitriptyline and nortriptyline inhibit interleukin-1 release by rat mixed glial and microglial cell cultures. Int J Neuropsychopharmacol 2006; 9: 27-35.
22. Kubera M, Holan V, Mathison R et al. The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology 2000; 25: 785-797.
23. Leduc C, Gentili ME, Estebe JP et al. The effect of local anesthetics and amitriptyline on peroxidation in vivo in an inflammatory rat model: preliminary reports. Anesth Analg 2002; 95: 992-996, table of contents.
24. Xiao L, Eneroth P. Tricyclic antidepressants inhibit human natural killer cells. Toxicol Appl Pharmacol 1996; 137: 157-162.
25. Yaron I, Shirazi I, Judovich R et al. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum 1999; 42: 2561-2568.
26. Chevalier RL. Molecular and cellular pathophysiology of obstructive nephropathy. Pediatr Nephrol 1999; 13: 612-619.
27. Fan JM, Ng YY, Hill PA et al. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999; 56: 1455-1467.
28. Jinde K, Nikolic-Paterson DJ, Huang XR et al. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 2001; 38: 761-769.
29. Kaneto H, Morrissey J, Klahr S. Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 1993; 44: 313-321.
30. El Chaar M, Chen J, Seshan SV et al. Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol 2007; 292: F1291-F1301.
31. Persy VP, Verhulst A, Ysebaert DK et al. Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 2003; 63: 543-553.
32. Wolf G, Jocks T, Zahner G et al. Existence of a regulatory loop between MCP-1 and TGF-beta in glomerular immune injury. Am J Physiol Renal Physiol 2002; 283: F1075-F1084.
33. Brady HR. Leukocyte adhesion molecules and kidney diseases. Kidney Int 1994; 45: 1285-1300.
34. Ishikura H, Takahashi C, Kanagawa K et al. Cytokine regulation of ICAM-1 expression on human renal tubular epithelial cells in vitro. Transplantation 1991; 51: 1272-1275.
35. Fulton B, Markham A. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 1996; 51: 278-298.
36. Hughes SE, Gruber SA. New immunosuppressive drugs in organ transplantation. J Clin Pharmacol 1996; 36: 1081-1092.
37. Nadeau KC, Azuma H, Tilney NL. Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil. Transplantation 1996; 62: 1363-1366.
38. Bayazit AK, Bayazit Y, Noyan A et al. Comparison of mycophenolate mofetil and azathioprine in obstructive nephropathy. Pediatr Nephrol 2003; 18: 100-104.
39. Tanda S, Mori Y, Kimura T et al. Histamine ameliorates anti-glomerular basement membrane antibody-induced glomerulonephritis in rats. Kidney Int 2007; 72: 608-613.
40. Diamond JR, Pesek-Diamond I. Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: role of macrophages. Am J Physiol 1991; 260: F779-F786.